National Comprehensive Cancer Network



About NCCN

New Chronic Myelogenous Leukemia Guidelines for Patients Available from NCCN

By Carrie Capili, Communications Specialist, Editor

The National Comprehensive Cancer Network® (NCCN®), with the support of the NCCN Foundation, recently announced the latest addition to the library of NCCN Guidelines for Patients™, the NCCN Guidelines for Patients™: Chronic Myelogenous Leukemia. This resource is a patient-friendly, easy-to-understand translation of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines™) for Chronic Myelogenous Leukemia (CML), which physicians use when determining appropriate cancer treatment. The NCCN Guidelines for Patients™ aim to help patients with cancer and their loved ones discuss the best treatment options for them with their physicians.

More than 4,500 new cases of CML are diagnosed in the United States each year, with most cases occurring in adults. CML is one of four major types of leukemia and accounts for 15 percent of adult leukemias. It is a leukemia that grows slowly and causes too many white blood cells to form. People diagnosed with CML often have more than one treatment option, including, but not limited to, tyrosine kinase inhibitors, chemotherapy, or hematopoietic stem cell transplantation.

The NCCN Guidelines™ are developed by multidisciplinary panels of experts from NCCN Member Institutions and feature algorithms or “decision trees” that address every appropriate management option from initial work-up throughout the course of the disease. The NCCN Guidelines for Patients™ translate these professional guidelines in a clear, step-by-step manner that patients can use as the basis for making decisions and discussing treatment options with their physicians.

The NCCN Guidelines for Patients™ are available free of charge at NCCN.com, which, in addition, features informative articles for patients and caregivers. NCCN also offers six other NCCN Guidelines for Patients™ including Breast, Non-Small Cell Lung, Ovarian and Prostate Cancers, and Melanoma and Multiple Myeloma. By the end of 2011, NCCN aims to have 10 new and updated NCCN Guidelines for Patients™ added to the library, with the next NCCN Guidelines for Patients™ for Malignant Pleural Mesothelioma scheduled for release in the summer of 2011.

 

 

 

 

 

Quick Links


About NCCN| NCCN Member Institutions| Patient Resources| NCCN Foundation| Privacy Policy| Legal Notices| Contact Us

275 Commerce Drive, Suite 300, Fort Washington, PA 19034 • 215.690.0300 • Fax: 215.690.0280
Copyright © 2013 National Comprehensive Cancer Network, All Rights Reserved

z